Santa Ana Therapeutics
PrivateLast Round
Series B
Jun 13, 2024
Est. Valuation
$270M
Total Funding Raised
$168M
Company Overview
Santa Ana Therapeutics is a biotechnology company developing precision medicines for autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Santa Ana Therapeutics Comparables
Compare Santa Ana Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mirador Therapeutics | 87% | |
| Seismic | 83% | |
| UCB | 82% | |
Santa Ana Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 13, 2024 | ||||
| Series A | Jun 13, 2024 |
Santa Ana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series B |
| GV | Series A, Series B |
| Versant Ventures | Series B, Series A |
| RTW Investments | Series B |
| Access Biotechnology | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 13, 2024
$125M round led by GV
Santa Ana Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Santa Ana Therapeutics's valuation, stock price, and market status.